Latest Shareholder Value News

DigitalX Limited has boosted its treasury valuation to A$104 million, driven by a strategic Bitcoin-first approach that now totals nearly 500 BTC. The company aims to more than quadruple its Bitcoin holdings by 2027, underscoring its confidence in digital assets as a core treasury component.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Helia Group reports a robust 38% rise in statutory net profit for the first half of 2025, alongside a special dividend declaration, while navigating looming challenges from government policy shifts and lender contract changes.

Helia Group Limited reported a strong first half of 2025 with a 37.8% jump in net profit, driven by investment gains and low claims, but faces significant challenges as major contracts with Commonwealth Bank and ING Bank are set to end in 2026.

Coast Entertainment Holdings Limited reported a robust FY25 with record revenue and EBITDA growth, driven by strong visitor numbers and the successful launch of new attractions. The company’s momentum continues into FY26 amid ongoing macroeconomic challenges.

Coast Entertainment Holdings reports its strongest financial year since 2016, driven by a surge in ticket sales and new attractions, while FY26 begins with robust growth and strategic initiatives.

Boom Logistics reported solid FY25 results with a 41% jump in operating profit, driven by strong contract wins in resources and renewables and a strategic asset regeneration program.

Boom Logistics has reported a robust FY25 performance, with a 38% increase in operating earnings per share, underpinned by strong renewables and transmission projects despite challenges in resources and infrastructure.

Credit Clear Limited reported a strong FY25 with 12% revenue growth and a 76% jump in underlying EBITDA, driven by digital innovation and client expansion. The company sets an ambitious FY26 outlook alongside a new share buy-back program.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.